Medicine
Phyrago 70 mg tablet
Phyrago 70 mg tablet is a prescription medicine containing Dasatinib for oral use, marketed by Cycle Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
PHYRAGO should be stored at 20°C to 25°C (68°F to 77°F), excursions permitted…
Key facts
- Active ingredient (INN)
- Dasatinib
- Brand
- Phyrago
- Strength
- 70 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets
- Marketing authorisation holder
- Cycle Pharmaceuticals
- Manufacturer
- Cycle Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- PHYRAGO should be stored at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01EA02 Dasatinib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 September 2025
- Identifiers
- RxCUI 643105, 643107, 643109 +7DailyMed set ID 60976d1e-c415-417f-8168-4e07999a7281NDC 70709-153Application NDA216099
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet in 1 bottle | 70709-153-70 | Cycle Pharmaceuticals | 22 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Dasatinib 70 mg tablet.
Other strengths and forms of Dasatinib
Clinical summary
Dasatinib is a kinase inhibitor indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Dasatinib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DasatinibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SPRYCEL prescribing information (ER Squibb & Sons) · U.S. National Library of Medicine, DailyMed
- Sprycel: European public assessment report (EPAR) · European Medicines Agency
- Dasatinib Accord Healthcare: European public assessment report (EPAR) · European Medicines Agency
Need Phyrago 70 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.